Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
First patients dosed in groundbreaking trial targeting a common Cancer-Causing gene
Disease control OngoingThis is the first time a new drug called ASP4396 is being given to people. The study aims to find a safe dose and understand how the body handles it. It is for adults with advanced solid tumors that have spread and carry a specific genetic change called KRAS G12D, who have few ot…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for leukemia patients who run out of options
Disease control OngoingThis study tested whether a new targeted pill (gilteritinib) works better than standard chemotherapy for adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to first treatment. The goal was to see if the new drug helps patients live long…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Year-Long trial tests safety of new hot flash pill for menopausal women
Symptom relief OngoingThis study aims to confirm the long-term safety of fezolinetant, a non-hormonal medication for menopausal hot flashes, in Japanese women. Over 270 participants will take either the drug or a placebo daily for up to one year while doctors monitor their health. The goal is to gathe…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Symptom relief
Last updated Mar 04, 2026 15:29 UTC